Methylprednisolone Recruiting Phase 2 Trials for Disseminated Sclerosis Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02784210Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
NCT03674099Imatinib for Multiple Sclerosis (MS) Relapses